糖皮质激素在非酒精性脂肪肝发展中的作用

被引：10

作者：

田颖新

王冰

邱红

机构：

[1] 解放军第八一医院

来源：

肝脏 | 2015年 / 20卷 / 01期

关键词：

D O I：

10.14000/j.cnki.issn.1008-1704.2015.01.023

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

100201 [内科学];

摘要：

<正>流行病学显示全球近三十年来非酒精性脂肪肝（NAFLD）患者明显增多,不但西方国家的发病率高达人群的20%30%,而且近几年亚太地区发病率也达到10%45%,且还在迅速增高[1]。中国近些年来随着经济的发展与国内外文化交流的增多,人们的生活方式及饮食结构发生了极大的改变,造成NAFLD患者日益增多,研究显示NAFLD在与代谢综合征（MS）有关的肥胖及2型糖尿病等患者中发病率明显增加[2,3],

引用

页码：79 / 81

页数：3

共 9 条

[1]

非酒精性脂肪性肝病与代谢综合征相关性的研究进展 [J].

尹秀梅 ;

缪珩 .

医学综述, 2013, 19 (17) :3186-3189

[2]

米非司酮在胰岛素抵抗中对脂质代谢的影响 [J].

乔丽云 ;

丁启龙 .

中国药科大学学报, 2008, (02) :169-173

[3]

Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome [J].

Salamone, Federico ;

Bugianesi, Elisabetta .

JOURNAL OF HEPATOLOGY, 2010, 53 (06) :1146-1147

[4]

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications [J].

Fabbrini, Elisa ;

Sullivan, Shelby ;

Klein, Samuel .

HEPATOLOGY, 2010, 51 (02) :679-689

[5]

The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective [J].

Lazo, Mariana ;

Clark, Jeanne M. .

SEMINARS IN LIVER DISEASE, 2008, 28 (04) :339-350

[6]

Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice [J].

Bonnard, Charlotte ;

Durand, Annie ;

Peyrol, Simone ;

Chanseaume, Emilie ;

Chauvin, Marie-Agnes ;

Morio, Beatrice ;

Vidal, Hubert ;

Rieusset, Jennifer .

JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02) :789-800

[7]

Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary.[J].Geoffrey CFarrell;ShivakumarChitturi;George KKLau;José DSollano.Journal of Gastroenterology and Hepatology.2007, 6

[8]

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease [J].

Targher, G ;

Bertolini, L ;

Rodella, S ;

Zoppini, G ;

Zenari, L ;

Falezza, G .

CLINICAL ENDOCRINOLOGY, 2006, 64 (03) :337-341

[9]

Oxidative capacity; lipotoxicity; and mitochondrial damage in type 2 diabetes..Schrauwen P; Hesselink MK;.Diabetes.2004,

← 1 →